Searchable abstracts of presentations at key conferences in endocrinology

ea0026p46 | Endocrine disruptors | ECE2011

Bone remodeling parameters and bone mass in patients with schizophrenia treated with long-acting injectable risperidone

Doknic M , Bojovic N Maric , Pekic S , Britvic D , Damjanovic A , Gasic M Jasovic , Popovic V

Introduction: Studies suggest that schizophrenia and prolactin raising antipsychotics, one of them being risperidone, may be associated with low bone mass. On the other hand, weight gain as a consequence of antipsychotics in these patients may be the protective factor against osteoporosis.Objective: Determine bone remodeling parameters and bone mass in patients with schizophrenia treated with long-acting injectable risperidone (LAIR) under naturalistic c...